Essentia Biosystems Announces $13 Million Financing; Company Developing Novel Therapeutic Products in Aesthetics and Dermatology.

Business Editors/Health/Medical Writers

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–April 26, 2004

Essentia Biosystems, Inc., a private pharmaceutical company, announced the completion of a $13 million Series B financing. The company is focusing on the development and commercialization of the next generation of aesthetic and therapeutic dermatology dermatology

Recommended Reads....

Please Share Us:
Votes 94

Rating: 4 out of 5

Site Disclaimer: This site is designed for educational purposes only, if you click on a link and make a purchase I will make a small commission. Furthermore, all videos and photos on this site are provided by 3rd parties. We take no responsibility for the content on any website which we link to, please use your own discretion while surfing the links.

Frontier Theme

Enjoy this blog? Please spread the word :)